期刊文献+

急性冠脉综合征患者血清HsCRP和IFN-γ的检测及意义 被引量:8

The analysis of level High-sensitivity C-reactive protein and Interferon-γ for acute coronary syndrome(ACS) patients
下载PDF
导出
摘要 目的探讨急性冠脉综合征(ACS)患者血清超敏C反应蛋白(HsCRP)和干扰素γ(IFN-γ)水平变化,为临床判断冠状动脉粥样硬化(AS)斑块性质提供理论依据。方法选择行冠状动脉造影患者76例,为ACS组其中急性心肌梗死(AMI)28例,不稳定型心绞痛(UAP)48例;正常对照组20例。分别应用酶联免疫吸附实验(ELISA法)检测血清IFN-γ水平和乳胶增强免疫比浊法检测血清HsCRP。结果 ACS患者血清HsCRP(9.55±6.94)mg/L和IFN-γ(1071.86±496.19)pg/mL水平明显高于正常对照组HsCRP(0.96±0.69)mg/L和IFN-γ(458.62±116.48)pg/mL(P<0.05);AMI组患者血清HsCRP(15.60±4.17)mg/L和IFN-γ(1442.15±649.85)pg/mL水平明显高于UAP组HsCRP(6.01±5.68)mg/L和IFN-γ(855.86±158.88)pg/mL(P<0.05)。结论 IFN-γ和HsCRP血清水平可以作为判断AS斑块不稳定性的指标,也参与AS斑块由静止状态向活动状态转化并导致斑块破裂的过程。 【Objective】 To study high sensitive C reactive protein(HsCRP) and interferon(IFN-γ) level in acute coronary syndrome(ACS) patients' serum,for the clinical diagnosis of coronary atherosclerosis(AS) plaque and provide a theoretical basis.【Methods】 Patients received coronary angiography 76 Cases of ACS divided into group acute myocardial infarction(AMI) 28 cases and unstable angina pectoris(UAP) 48 cases,and normal controls group 20 cases.Application of enzyme linked immunosorbent assay(ELISA) for detection of serum HsCRP and IFN-γ levels.【Results】 The ACS patients with serum HsCRP and IFN-γ levels were significantly higher than those in normal control group(P 0.05);group AMI patients with serum HsCRP and IFN-γ levels were significantly higher than in group UAP(P 0.05).【Conclusion】 IFN-γ and HsCRP serum levels can be used as a AS plaque instability index,are also involved in AS plaque from stationary state to active state transformation and leading to plaque rupture process.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2013年第12期34-37,共4页 China Journal of Modern Medicine
关键词 干扰素Γ 超敏C反应蛋白 急性冠脉综合征 Interferon-γ high-sensitivity C-reactive protein acute coronary syndrome
  • 相关文献

参考文献11

  • 1HOFFE MEISTER HM, EHLERS R, BUTFCHER K, et at. Comparison of C-reactive proteinand terminal complement com- plex in patients with unstable anginapectoris versus stable angina pectoris[J]. Am J Cardiol, 2002, 89: 909-912. 被引量:1
  • 2RIDKER PM. High -sensitivihy C-reactive protein :potential ad- junctfor global risk assessmentin the primary primary prevention of cardiovasculardisease[J]. Circulation, 2001, 103: 1813-1818. 被引量:1
  • 3ZHAO Q. Inflammation, autoimmunit y and atherosclerosis[J]. Discov Med, 2009, 8(40): 7-12. 被引量:1
  • 4HUA Y, XUE J ,SUN F, et al. Aspirin inhibits MMP-2 and MMP-9 expressions and activities through upregulation of PPA- R c: / 3' and TIMP gene expressions in ox-LDL-stimulated macrophages derived from human monocytes [J]. Pharmacology, 2009, 83(1): 18-25. 被引量:1
  • 5KU BEN SKII GE, ARDASHEV VN, CHERNOV SA, et ab The cell immunity parameters in patients with acute coronary syn- drome[J]. Klin Med (Mosk), 2006, 84(2): 32-35. 被引量:1
  • 6BRAUNWAL E, ANTMAN EM, BEASLEY JW, et at, ACC/AHA Guidelines for the management of patients with unslable angina and non-ST-segment elevation myocardial infarction. A report of American college of Cardiology/American Heart Association Task Force on Practice Guidelines[J]. J Am Coil Cardiol, 2000, 36: 970-1062. 被引量:1
  • 7黄广勇,卢才义,李义波,吴兴利.高敏C反应蛋白与老年冠心病患者冠状动脉病变及对心脏事件的预测作用[J].中华老年心脑血管病杂志,2008,10(10):737-739. 被引量:12
  • 8丘世飏,易斌,黄大毛,冷如意.老年下肢深静脉血栓患者血清超敏C反应蛋白、脂蛋白(a)水平分析[J].中国老年学杂志,2009,29(12):1564-1565. 被引量:3
  • 9郑华,吴赛珠,赖文岩.冠心病与T细胞增殖反应的相关性[J].中华老年心脑血管病杂志,2008,10(9):665-667. 被引量:4
  • 10WEYAND CM ,GORONZY JJ, LIUZZO G, et al. T-cell immu- nity inacute coronary syndromes [J]. Mayo Clin Proc, 2001, 76 (10): 1011-1020. 被引量:1

二级参考文献30

共引文献23

同被引文献67

  • 1谭利华.生脉汤加减配合西药治疗冠心病临床分析[J].辽宁中医学院学报,2006,8(3):82-82. 被引量:3
  • 2杨敏,陈广玲,陈畅,张钰,闫纯英.人参皂甙Rg1对大鼠急性心肌梗死的治疗作用[J].中西医结合心脑血管病杂志,2007,5(11):1075-1077. 被引量:26
  • 3NAVARRA T, DELTURCO S, BERTI S, et al. The lectin-likeoxidized lowdensity lipoprotein receptor-1 and its soluble form:cardiovascular implications[J]. J Atheroscler Thromb, 2010,17(4):317-331. 被引量:1
  • 4HAYASHIDA K, KUME N, MURASE T, et al. Serum solublelectin-like oxidized low-density lipoprotein receptor-1 levels areelevated in acute coronary syndrome: a novel marker for earlydiagnosis[J]. Circulation, 2005, 112: 812-818. 被引量:1
  • 5ARMSTRONG EJ, MORROW DA, SABATINE MS. Inflammatorybiomarkers in acute coronary syndromes: part II: acute-phase re-actants and biomarkers of endothelial cell activation[J]. Circulation,2006,113(7): 152-155. 被引量:1
  • 6吴超,杨跃进.高敏C反应蛋白在冠心病中应用的新进展[J].中华老年心脑血管病杂志,2008,10(1):69-71. 被引量:38
  • 7Aukrust P,Sandberg WJ,Otterdal K,et al .Tumor necrosis factorsuperfamily molecules in acute coronary syndromes[J].Annalsof Medicine,2011,43(2):90 -103. 被引量:1
  • 8Hohensinner PJ,Niessner A,Huber K,et al . Inflammation andcardiac outcome [J]. Current Opinion in Infectious Diseases,2011,24(3):259 -264. 被引量:1
  • 9Wolk R,Bertolet M,Brooks MM,et al .Differential effects of insu- lin sensitization and insulin provision treatment strategies onconcentrations of circulating adipokines in patients with diabetesand coronary artery disease in the BARI 2D trial[J].EuropeanJournal of Preventive Cardiology,2016,23(1):50-58. 被引量:1
  • 10Narverud I,Ueland T,Nenseter MS,et al .Children with familialhypercholesterolemia are characterized by an inflammatory im- balance between the tumor necrosis factor system and interleu- kin 10[J].Atherosclerosis,2011,214(1):163-168. 被引量:1

引证文献8

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部